GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (LTS:0NLV) » Definitions » Change In Payables And Accrued Expense

Vita 34 AG (LTS:0NLV) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG Change In Payables And Accrued Expense?

Vita 34 AG's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was €0.00 Mil. It means Vita 34 AG's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Sep. 2023 .

Vita 34 AG's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means Vita 34 AG's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Dec. 2022 .


Vita 34 AG Change In Payables And Accrued Expense Historical Data

The historical data trend for Vita 34 AG's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG Change In Payables And Accrued Expense Chart

Vita 34 AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vita 34 AG Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vita 34 AG Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita 34 AG Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita 34 AG (LTS:0NLV) Business Description

Industry
Traded in Other Exchanges
Address
Deutscher Platz 5a, Leipzig, DEU, D-04103
Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.

Vita 34 AG (LTS:0NLV) Headlines

No Headlines